Cwm, LLC Actinium Pharmaceuticals, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 3,203 shares of ATNM stock, worth $3,587. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,203

Previous 102 3040.2%

Holding current value

$3,587

Previous $1,000 500.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$1.72 - $8.0 $5,333 - $24,808	3,101 Added 3040.2%	3,203 $6,000
Q2 2024 Jul 09, 2024	BUY	$6.56 - $9.89 $72 - $108	11 Added 12.09%	102 $1,000
Q1 2024 Apr 05, 2024	SELL	$5.0 - $9.2 $430 - $791	-86 Reduced 48.59%	91 $1,000
Q4 2023 Feb 01, 2024	BUY	$4.02 - $6.08 $309 - $468	77 Added 77.0%	177 $1,000
Q4 2022 Feb 01, 2023	SELL	$7.05 - $14.41 $10,730 - $21,932	-1,522 Reduced 93.83%	100 $1,000
Q4 2021 Jan 31, 2022	BUY	$6.01 - $8.8 $745 - $1,091	124 Added 8.28%	1,622 $10,000
Q1 2021 Sep 15, 2021	BUY	$7.62 - $9.79 $11,087 - $14,244	1,455 Added 3383.72%	1,498 $12,000
Q1 2021 Apr 27, 2021	SELL	$7.62 - $9.79 $11,087 - $14,244	-1,455 Reduced 97.13%	43 $0
Q4 2020 Sep 15, 2021	BUY	$7.8 - $12.64 $11,684 - $18,934	1,498 New	1,498 $12,000
Q4 2020 Jan 27, 2021	SELL	$7.8 - $12.64 $11,684 - $18,934	-1,498 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$7.26 - $18.0 $10,875 - $26,964	1,498 New	1,498 $12,000
Q3 2020 Oct 19, 2020	SELL	$7.26 - $18.0 $10,875 - $26,964	-1,498 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$5.25 - $13.62 $7,864 - $20,402	1,498 New	1,498 $12,000
Q2 2020 Jul 22, 2020	SELL	$5.25 - $13.62 $7,864 - $20,402	-1,498 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$5.25 - $8.82 $7,864 - $13,212	1,498 New	1,498 $12,000
Q1 2020 Apr 28, 2020	SELL	$5.25 - $8.82 $7,864 - $13,212	-1,498 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$5.88 - $10.59 $8,808 - $15,863	1,498 New	1,498 $12,000
Q4 2019 Jan 27, 2020	SELL	$5.88 - $10.59 $8,808 - $15,863	-1,498 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$6.06 - $8.04 $9,077 - $12,043	1,498 New	1,498 $12,000
Q3 2019 Oct 22, 2019	SELL	$6.06 - $8.04 $9,077 - $12,043	-1,498 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$7.32 - $18.0 $10,965 - $26,964	1,498 New	1,498 $12,000
Q2 2019 Jul 31, 2019	SELL	$7.32 - $18.0 $10,965 - $26,964	-1,498 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$12.9 - $19.5 $19,324 - $29,211	1,498 New	1,498 $0

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.31M

Call Options Held

65.2K

Put Options Held

21.7K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $28.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account